7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Brain & Nerves

Who Is a Candidate for Deep Brain Stimulation in Parkinson’s Disease? How Teams Decide

24 min read
Who Is a Candidate for Deep Brain Stimulation in Parkinson’s Disease? How Teams Decide

Key Takeaways

  • DBS tends to help the Parkinson's symptoms that levodopa helps, which is why a formal on-off levodopa challenge is the single most informative part of the assessment.
  • Tremor is the main exception: it can respond to stimulation even when medicine has only partly controlled it.
  • Freezing, balance loss, soft speech and swallowing trouble that persist during good "on" periods rarely improve with DBS and may worsen.
  • No guideline sets an age limit; teams weigh cognition, brain-vessel health, frailty and other illnesses rather than the number.
  • Stimulation is typically switched on a few weeks after surgery and refined over several months, alongside medicine adjustments made by the prescribing clinician.
  • A "not now" usually points to a specific, often correctable issue, so asking what would change the recommendation is a fair and answerable question.
Quick Answer

A person is usually considered a candidate for deep brain stimulation in Parkinson's disease when the diagnosis is confirmed, symptoms still respond well to levodopa but the response has become unpredictable or dyskinesias are troublesome, and memory, mood and general health are stable enough for brain surgery. A multidisciplinary team makes the decision after a structured assessment, and it can change over time.

She had the timer on her phone set for every dose, and she still could not count on the afternoon. Some days the medicine kicked in and the tremor melted away for hours. Other days it arrived late, wore off early, and left her stiff in the grocery aisle with a cart she could barely push. Her neurologist had used a phrase that sounded both hopeful and slightly alarming: it might be time to think about whether she was a dbs candidate parkinsons teams would take seriously.

That sentence sends thousands of people to the internet each year, and most of what they find is either a brochure or a horror story. Neither is much use. The real answer lives in a careful process, run by a team, that weighs how the disease behaves, how the brain and body are coping, and what the person actually wants their days to look like.

This explainer walks through that process the way a good clinic would, without the sales pitch and without the fear.

Why the dbs candidate parkinsons question rarely has a yes-or-no answer

Deep brain stimulation, usually shortened to DBS, is a surgical treatment in which thin electrodes are placed in specific parts of the brain and connected to a small battery-powered device that delivers steady electrical pulses. It has been used for Parkinson’s disease for decades and is well described by Mayo Clinic and the National Institute of Neurological Disorders and Stroke (NINDS). What it is not is a treatment that suits everyone with Parkinson’s, or one that a single doctor signs off on after a ten-minute visit.

Candidacy sits on a sliding scale rather than a switch. Someone might be a poor fit today because their diagnosis is only two years old and pills still work smoothly, then become a strong fit five years later when the same pills produce a rollercoaster of good and bad hours. Another person might have textbook motor symptoms but early memory changes that push the balance toward waiting or toward other options.

Teams therefore ask three linked questions. Is this really idiopathic Parkinson’s disease, the common form with no identifiable cause, rather than one of the look-alike conditions that respond poorly to stimulation? Are the symptoms that trouble this person the kind DBS is known to help? And is the whole person, including thinking, mood, other illnesses and support at home, in a place where surgery and the demanding months of adjustment afterward make sense?

The rest of this article unpacks each of those questions. Keep one idea in mind throughout: the goal of the assessment is not to find a reason to say no. It is to make sure that when a team says yes, the person on the operating table has a realistic chance of benefiting, and understands exactly what that benefit looks like.

How deep brain stimulation actually works, in plain language

Parkinson’s disease damages cells in a small region deep in the brain that produce dopamine, a chemical messenger the brain uses to make movement smooth and automatic. As dopamine falls, circuits that coordinate movement start firing in abnormal, overly synchronized patterns. The result is tremor, slowness, stiffness and, over time, an unreliable response to the medicines that replace the missing dopamine.

Healthcare provider observing elderly patient eating meal: How deep brain stimulation actually works, in plain language

DBS does not add dopamine and does not repair the damaged cells. Instead, as NINDS and Johns Hopkins describe it, the electrodes deliver a rapid, continuous stream of tiny electrical pulses into one of the malfunctioning hubs of that movement circuit. The most common targets are the subthalamic nucleus, a lentil-sized cluster of cells that acts as a brake on movement, and the globus pallidus interna, a nearby output station. Steady stimulation disrupts the abnormal firing pattern, which lets the circuit behave more normally.

The hardware has three parts. The leads are hair-thin wires with several metal contacts at the tip, positioned in the brain during surgery. An extension wire runs under the skin of the scalp and neck. A pulse generator, roughly the size of a matchbox, sits under the skin of the chest and houses the battery and the electronics. A clinician uses a handheld programmer to adjust which contacts are active and how strong the stimulation is, and the person carries a smaller controller to check the device or switch it on and off if told to.

Two features make DBS distinctive among treatments for Parkinson’s. It is adjustable, so settings can be tuned for months as symptoms change. And it is reversible in the sense that the stimulation can be turned off and the hardware can, if needed, be removed. Those properties are part of why teams are willing to offer it to selected people, and also why the months after surgery matter as much as the operation itself.

Who qualifies for DBS surgery? The typical profile

Ask a movement disorders neurologist to sketch the person they most expect to benefit, and the picture is fairly consistent across guidelines from the NHS, NINDS and major academic centers. Several features tend to appear together.

The diagnosis is idiopathic Parkinson’s disease, confirmed over time by a specialist. Look-alike conditions such as multiple system atrophy or progressive supranuclear palsy, which are grouped as atypical parkinsonism, respond poorly to stimulation, so teams want to be confident about the label. Because these conditions can be hard to distinguish in the first few years, many programs are cautious about operating early; the NHS notes that DBS is generally reserved for people whose symptoms are not controlled well by medicine.

The symptoms still respond to levodopa, the main dopamine-replacing medicine, but the response has become unreliable. People describe motor fluctuations: predictable or unpredictable swings between “on” periods, when medicine is working, and “off” periods, when it is not. Many also have dyskinesia, involuntary writhing or fidgeting movements that appear when medicine levels peak. That pattern of good hours and bad hours, despite a well-optimized regimen, is the single most common reason teams move toward DBS.

Tremor that has not settled with medicine is another strong indication, even when other symptoms are mild, because tremor tends to respond particularly well to stimulation.

Beyond the movement picture, the profile includes stable memory and thinking on formal testing, mood that is treated and reasonably steady, no other medical condition that would make anesthesia or brain surgery unusually risky, and enough support at home to manage the many follow-up visits. Finally, and this matters more than people expect, the person has realistic goals and has understood what the treatment can and cannot change.

Nobody needs to tick every box perfectly. The team weighs the whole picture, then discusses it openly.

Who is usually asked to wait, and why

Being told “not yet” is common, and it is not a verdict on how hard someone’s Parkinson’s is. It usually reflects one of a handful of situations that make the risk-to-benefit balance unfavorable at that moment.

Elderly patient eating meal with doctor discussing nutrition: Who is usually asked to wait, and why

The most frequent is simply that medicine is still doing its job. If doses can be rearranged, a longer-acting formulation tried, or an add-on class introduced with good results and few side effects, most teams would rather do that first. Surgery carries fixed risks; a medication adjustment carries fewer. Mayo Clinic frames DBS as an option for people whose symptoms are not adequately controlled with medicine, and that word “adequately” leaves room for a lot of fine-tuning.

Uncertainty about the diagnosis is the second reason. Early in the disease, features that point toward an atypical form may not have emerged. Waiting a year or two can clarify the picture and spare someone an operation that would not have helped.

Cognitive concerns are a third. When neuropsychological testing, a structured set of memory, attention and problem-solving tasks, shows meaningful impairment, teams often advise against DBS because stimulation can worsen thinking in some people and because managing the device demands good executive function. The same applies to active, poorly controlled depression or psychosis, which need treating and stabilizing before surgery is reconsidered.

Other health problems weigh in too. Uncontrolled high blood pressure, a bleeding tendency, certain heart conditions or a recent stroke can raise surgical risk enough that the team pauses.

Finally, some people are asked to wait because their main troubles are ones DBS does not address well, such as severe balance loss, frequent falls, or speech and swallowing difficulty. In those cases, the honest conversation is less about timing and more about which treatments realistically fit the symptoms that matter.

What is the levodopa challenge test for DBS, and why it matters most

If one part of the assessment deserves the label “most important,” it is the levodopa challenge, sometimes called an on-off test. The logic is elegant and has held up for decades: for the motor symptoms of Parkinson’s, DBS tends to help the things levodopa helps, and to leave alone the things levodopa leaves alone. Measuring the medicine’s best effect therefore gives the team a preview of what stimulation might do.

The test is organized around two examinations by the same clinician, ideally on the same morning. The first happens in the “off” state, after the person has held their usual Parkinson’s medicine overnight for a period the team specifies. The neurologist scores movement using a standardized rating scale that covers tremor, stiffness, slowness, walking, balance and speech. The person then takes their normal medicine, or a dose the team has planned, and waits for it to work, which typically takes up to about an hour. The examiner repeats the same scale in the “on” state.

A clear, substantial improvement between the two scores is encouraging, because it confirms both the diagnosis and that the circuits DBS acts on are the ones misbehaving. A small difference is a caution flag. It can mean the diagnosis needs revisiting, or that the dominant problems are ones stimulation rarely improves.

Two useful exceptions exist. Tremor that does not respond fully to levodopa can still respond to DBS, so a modest tremor score is not disqualifying. And troublesome dyskinesia, which the test may provoke, is itself a target; the team notes it rather than counts it against the person.

People often find the off period uncomfortable, and it is fair to say so in advance. Teams schedule the test early, provide a quiet space, and let the person take their medicine as soon as the off examination is complete. The information gathered in that one morning shapes almost every conversation that follows.

Deep brain stimulation eligibility: how the team assessment unfolds

Eligibility for DBS is decided by a group, not an individual, and the process is deliberately slow. A typical evaluation stretches across several visits over weeks to months, and most people describe it as thorough rather than intimidating once they know what to expect.

The movement disorders neurologist leads. This is a neurologist with extra training in Parkinson’s and related conditions who confirms the diagnosis, reviews the medication history, performs the levodopa challenge and defines which symptoms the surgery is meant to address.

A neuropsychologist tests memory, attention, language and problem-solving. The point is not to find a perfect score but to spot the patterns that predict poorer outcomes, and to establish a baseline so any changes after surgery can be tracked.

A psychiatrist or psychologist screens for depression, anxiety, apathy and impulse-control problems, all of which are common in Parkinson’s and all of which can shift after stimulation begins.

The neurosurgeon reviews brain imaging, usually magnetic resonance imaging (MRI), which uses magnetic fields rather than radiation to picture the brain, to check that the target regions are clearly visible and that nothing such as extensive small-vessel disease or a structural abnormality would make the procedure riskier. The surgeon also explains the operative steps and their risks.

An anesthesiologist and often an internist assess fitness for surgery, looking at heart, lung and blood-pressure health, medicines that affect bleeding, and any prior reactions to anesthesia.

Physical, speech and occupational therapists frequently contribute, particularly around walking, balance, voice and swallowing, because these tell the team which day-to-day goals are realistic.

The findings are then discussed at a case conference. Some programs describe this as a board or panel. The outcome may be a recommendation to proceed, a recommendation to optimize medicine and reassess later, or a recommendation against surgery with an explanation of alternatives. In every version, the person and their family get the reasoning, and the final decision stays with them and their treating team.

Is there a DBS surgery age limit?

There is no fixed number written into any major guideline, and teams are increasingly wary of using one. Parkinson’s most often begins after age 60, according to NINDS, so many people being evaluated are in their sixties and seventies. What matters is not the birthdate but the biology behind it.

Older age tends to travel with things that do change the calculation. Memory and thinking are more likely to have shifted. Blood vessels in the brain may be less healthy, which raises the risk of bleeding during electrode placement. Other conditions such as heart disease, diabetes or kidney problems become more common and add to anesthetic risk. Recovery from any surgery is generally slower, and the programming visits that follow demand travel, patience and stamina. Balance and gait problems, which DBS helps least, are more prominent in older people with longer disease duration.

Younger age brings its own considerations. People diagnosed in their forties or fifties often have decades of life ahead and may reach the stage of disabling fluctuations relatively early. For them, the discussion frequently turns to timing: whether to intervene while quality of life is still good, or to hold off. Research has explored DBS in people with earlier motor complications, and the finding that it can be considered before disability becomes severe has shaped practice. That said, “earlier” still means after fluctuations have appeared, not soon after diagnosis.

The practical upshot is that a healthy, cognitively sharp 74-year-old with disabling fluctuations may be a stronger candidate than a 58-year-old with early memory loss. Programs assess frailty, cognition and cardiovascular health individually rather than drawing a line at a particular age. If someone is told they are “too old,” it is reasonable to ask which specific factor the team is worried about, because the answer is usually one of the concrete issues above rather than the number itself.

Which Parkinson's symptoms respond to DBS, and which do not

Expectations are where candidacy conversations most often go wrong, so it helps to see the pattern laid out. The table below summarizes what mainstream evidence, as described by Mayo Clinic, Johns Hopkins and NINDS, generally shows about motor symptoms and DBS. Individual results vary, and the treating team will give a personalized view.

Symptom or problem Typical response to DBS Why
Tremor Often improves substantially Tremor circuits are directly influenced by stimulation, even when levodopa response is partial
Stiffness (rigidity) and slowness (bradykinesia) Often improves, roughly in line with best levodopa effect Same circuits that medicine acts on
Motor fluctuations (“on” and “off” swings) Often smoother, with more predictable “on” time Stimulation is continuous rather than tied to pill timing
Dyskinesia Often reduced Direct effect at some targets; also allows medicine changes at the team’s discretion
Freezing of gait and balance problems present in the “on” state Usually little or no improvement; can worsen Involves circuits outside the stimulation targets
Speech softness and slurring Little improvement; may worsen in some Speech pathways sensitive to stimulation spread
Swallowing difficulty Not reliably improved Not a levodopa-responsive symptom for most
Memory, thinking, mood, sleep, constipation, blood-pressure drops Not a target; some may change Non-motor symptoms driven by disease spread beyond motor circuits

The pattern is not accidental. DBS is, in effect, a way of delivering something like the person’s best “on” state more of the time, with fewer peaks and troughs. Anything that persists during a good “on” period, from freezing to a soft voice, is unlikely to yield to stimulation. Teams spend a great deal of the assessment identifying which category each troubling symptom falls into, and choosing between targets partly on that basis; stimulation of the globus pallidus, for example, is sometimes favored when dyskinesia dominates or when cognition is a concern.

What are the risks of deep brain stimulation surgery?

Every honest candidacy discussion covers what can go wrong, and a good team does this without either minimizing or dramatizing. The risks fall into three groups, as outlined by Mayo Clinic and MedlinePlus.

Surgical risks come from placing anything inside the skull. Bleeding in the brain is the most serious, because it can cause a stroke with lasting weakness, speech difficulty or, rarely, death. Infection can occur at the scalp, chest or along the wire, and sometimes requires removing hardware and treating with antibiotics before reimplantation. Seizures around the time of surgery, confusion in the first days, and the general risks of anesthesia round out the list. These events are uncommon, and centers track their own rates; asking a team for its figures is entirely appropriate.

Hardware risks appear later. Wires can break or move, the pulse generator can malfunction, skin over the device can erode, and batteries eventually need replacing through a smaller operation. Non-rechargeable batteries last years rather than months; rechargeable systems last longer but require the person to charge the device regularly, which itself demands a degree of organization.

Stimulation-related effects are the third group and the most adjustable. Tingling, muscle pulling, slurred speech, double vision, mood changes, apathy, impulsivity or worsened balance can appear when settings are changed. Most settle as the programmer refines the active contacts and strength. Some, particularly speech and gait changes, may persist as a trade-off against tremor or fluctuation control, and the person helps decide where that balance sits.

There is also a less tangible risk: disappointment. When someone expects symptoms that DBS does not treat to vanish, even a technically excellent result can feel like failure. That is exactly why the assessment invests so heavily in aligning expectations before anyone is scheduled for surgery.

What are the alternatives to DBS for advanced Parkinson's?

DBS is one option among several for people whose symptoms have outgrown standard pills, and a fair evaluation puts it side by side with the others. The choice depends on symptom pattern, cognition, surgical fitness and personal preference, and it rests with the treating team.

Medication optimization remains the first alternative, and it is often more powerful than people assume. Adjusting the timing of levodopa, adding a longer-acting or extended-release form, or introducing a medicine from a different class that prolongs dopamine’s effect or acts on other receptors can smooth fluctuations considerably. The NHS describes these classes in its treatment overview. The prescribing clinician makes these changes; they are not something to attempt independently.

Continuous drug delivery is the second family. Rather than relying on intermittent pills, medicine can be delivered steadily by a small pump under the skin or, for some formulations, through a tube placed directly into the small intestine. These approaches address the same fluctuation problem as DBS and may suit people for whom brain surgery is inadvisable, for instance because of cognitive concerns or medical frailty. They come with their own demands, including daily device care and skin or tube complications.

Focused ultrasound is a newer, non-incision procedure that uses concentrated sound waves guided by MRI to create a small, permanent lesion in a movement-related target. It is currently used mainly for tremor and is usually performed on one side of the brain. Because it is irreversible and not adjustable, it fits a different profile than DBS.

Around all of these sit the therapies that support every stage of Parkinson’s: physical therapy focused on gait and balance, speech and swallowing therapy, occupational therapy for daily tasks, regular exercise, and attention to mood, sleep and bone health. These are not consolation prizes. For symptoms DBS does not touch, they are the main event.

What the following weeks usually look like after DBS surgery

People often picture DBS as a single dramatic day. In reality the procedure is the start of a months-long process, and understanding that timeline is part of deciding whether to go ahead.

Surgery itself is frequently staged. Lead placement into the brain may be done with the person awake and talking, so the team can test effects in real time, or asleep with imaging guidance; both approaches are in mainstream use. The pulse generator is implanted in the chest either the same day or in a separate short operation. According to Mayo Clinic and MedlinePlus, a hospital stay of one to a few days is typical, followed by a recovery period at home measured in weeks, during which the scalp and chest incisions heal and activity is gradually increased.

Stimulation is usually not switched on immediately. Mayo Clinic notes that programming typically begins a few weeks after surgery, once swelling around the electrodes has settled. Interestingly, some people notice temporary improvement even before the device is activated, a phenomenon attributed to that swelling and the tiny disruption caused by lead placement. It fades, which can be disconcerting if no one has warned about it.

The first programming visit is long. The clinician tests each contact, notes benefits and side effects, and settles on an initial setting. Over the following three to six months, visits continue at intervals as settings are refined and the neurologist adjusts medicine to match. During this period symptoms can seem to bounce around, and people commonly report frustration before things stabilize.

Return to driving, work and travel is decided individually and depends on recovery, seizure risk in the early weeks and how symptoms are behaving. Anyone with an implanted device carries an identification card and should tell other clinicians before scans or procedures, since some MRI settings and certain electrical medical equipment need special precautions with DBS hardware.

What people often get wrong about being a dbs candidate parkinsons teams will accept

Misunderstandings about DBS cluster around a few durable myths. Correcting them early saves a lot of grief.

Myth: DBS is a last resort for people who have run out of options. Teams increasingly see it the other way round. The best results come while symptoms still respond to levodopa and before balance, cognition or general health decline. Waiting until someone is severely disabled can mean the window has closed, because the very features that grow with time are the ones that count against candidacy.

Myth: it is a one-time fix. The surgery is a beginning. Programming continues for months, medicine is usually still needed, batteries eventually require replacement, and Parkinson’s itself keeps progressing. DBS treats symptoms; it does not slow the underlying disease, a point NINDS makes plainly.

Myth: it will stop the falls. Balance problems and freezing that persist during good “on” periods rarely improve with stimulation and may worsen. Anyone whose main fear is falling should raise it explicitly, because the answer will shape whether DBS is even the right conversation.

Myth: if the levodopa response is weak, surgery will fill the gap. The relationship runs the opposite direction. A poor levodopa response predicts a poor DBS response for most symptoms other than tremor.

Myth: being turned down means the team thinks the Parkinson’s is not bad enough. A “not now” usually reflects specific, sometimes correctable, concerns: medicine that can still be optimized, cognition that needs fuller assessment, blood pressure that needs control. Asking what would change the recommendation is reasonable and often answered concretely.

Myth: DBS changes who you are. Personality is not a target, but mood, motivation and impulsivity can shift with stimulation, which is why mental-health screening is part of the assessment and why families are encouraged to report changes so settings can be adjusted.

Questions to ask your care team about DBS candidacy

The assessment is a two-way exchange. Arriving with a written list of questions helps people get the most from it and signals to the team that expectations are being examined carefully. These are the ones experienced neurologists most wish people would ask.

  • Which of my specific symptoms do you expect DBS to help, which do you expect it to leave unchanged, and which might it worsen?
  • What did my levodopa challenge show, and how does that shape your prediction?
  • Are you confident in the diagnosis of idiopathic Parkinson’s disease, and what features would make you reconsider?
  • What did my memory and mood testing show, and how does it affect the recommendation?
  • Which brain target are you proposing, on one side or both, and why that choice for me?
  • Will the leads be placed awake or asleep, and what are the reasons for that approach here?
  • What are this program’s own rates of bleeding, infection and hardware problems, and how many of these procedures does the team perform each year?
  • How will my medicines change after surgery, and who manages that?
  • How many programming visits should I expect in the first six months, and how long is each?
  • Rechargeable or non-rechargeable device, and what does each demand of me?
  • What would make you advise waiting, and what would need to change for you to recommend proceeding later?
  • What are the alternatives you would offer if I decide against surgery, or if I am not a suitable candidate?
  • Who do I call, day or night, if something worries me after the operation?

Bringing a family member or friend to these visits is worth the effort. They hear things the person may miss, they can describe symptoms observed at home, and they will be part of the support system that a successful DBS journey depends on. Writing down the answers, or asking permission to record the conversation, turns a stressful meeting into a document the household can return to when deciding.

When to call your doctor

Whether someone is being evaluated, waiting for surgery, or living with a device, certain changes need prompt attention rather than a note for the next appointment.

Before or during evaluation, contact the neurology team quickly if there is a sudden worsening of movement symptoms that does not follow the usual pattern, new confusion or hallucinations, a fall with head injury, or thoughts of self-harm. New severe depression or anxiety should be reported the same week; these conditions are treatable and they affect both safety and the candidacy decision.

After DBS surgery, seek urgent care or call emergency services for: sudden weakness or numbness on one side, trouble speaking or understanding, a severe headache unlike previous ones, a seizure, or a sudden change in alertness. These can signal bleeding in the brain, which is time-critical.

Call the surgical team the same day for signs of infection: redness, warmth, swelling or discharge at the scalp, neck or chest incision, fever, or skin over the device that looks thin, red or is breaking down. Report a sudden return of tremor or stiffness, which may mean the device has switched off or a wire has failed, and any shock-like sensation along the wire path.

New or worsening mood changes, unusual impulsivity such as gambling or overspending, marked apathy, or family concerns about personality should also be raised promptly with the programming team, since stimulation settings can often be adjusted.

Finally, before any medical procedure, MRI, surgery involving electrical cautery, or physical therapy using electrical devices, tell the clinician about the implant and ask them to check compatibility. Every decision about settings, medicines or further surgery belongs with the treating team; this article is a guide to the conversation, not a substitute for it.

Frequently asked questions

Who qualifies for DBS surgery in Parkinson's disease?

People most often considered have confirmed idiopathic Parkinson’s, a clear response to levodopa that has become unpredictable or complicated by dyskinesia, or tremor that medicine has not controlled, together with stable thinking, treated mood and reasonable surgical fitness. A multidisciplinary team decides after structured testing, and the decision can change as circumstances change.

Is there a DBS surgery age limit?

No major guideline sets one. Teams focus on what tends to accompany age: cognition, brain-vessel health, heart and lung fitness, frailty and balance. A healthy, cognitively sharp person in their seventies may be a better candidate than a younger person with early memory changes. If age is raised as a concern, ask which specific factor the team is weighing.

What is the levodopa challenge test and why is it used before DBS?

It compares movement scores after holding Parkinson’s medicine overnight with scores once medicine is working. Because DBS generally improves the same symptoms levodopa improves, a strong difference predicts benefit and supports the diagnosis, while a weak response is a caution flag. Tremor is an exception and can respond to stimulation even when medicine has not fully controlled it.

What are the deep brain stimulation eligibility tests?

The evaluation typically includes a detailed movement examination, the levodopa challenge, neuropsychological testing of memory and thinking, psychiatric screening for depression and impulse control, brain MRI to check the targets and rule out structural problems, and a medical and anesthetic fitness review. Therapists may assess gait, speech and swallowing. The findings are discussed at a team conference.

Can DBS slow down Parkinson's disease?

No. According to NINDS, DBS treats symptoms and does not slow or stop the underlying loss of dopamine-producing cells. Symptoms such as balance loss, cognitive change and speech difficulty may progress over time regardless of stimulation. The value of DBS lies in smoothing fluctuations, reducing dyskinesia and controlling tremor, not in changing the course of the disease.

Will I still need Parkinson's medicine after DBS?

Most people continue medicine after surgery, often with changes decided by their neurologist during the months of programming. DBS is designed to work alongside medication rather than replace it, and the balance between stimulation settings and medicine is adjusted individually. Any change to a prescribed medicine should come from the treating team, never from self-adjustment.

Why might a team say I should wait for DBS?

Common reasons include medicine that can still be optimized, uncertainty about whether the diagnosis is idiopathic Parkinson’s, memory or mood concerns that need fuller assessment or treatment, other illnesses that raise surgical risk, or main symptoms such as falls and speech problems that DBS does not treat well. Asking what would change the recommendation usually yields a concrete answer.

Does DBS help freezing of gait and falls?

Usually not. Freezing and balance problems that are present even when medicine is working well involve brain pathways outside the usual stimulation targets and often do not improve; in some people they worsen. Falls should be discussed explicitly during evaluation, because if they are the main concern, therapy-based approaches and medicine review may matter more than surgery.

How long after DBS surgery is the device turned on?

Mayo Clinic notes that programming typically begins a few weeks after surgery, once swelling around the electrodes has settled. Some people notice temporary improvement before activation, which fades. Settings are then refined over roughly three to six months of visits, with the neurologist adjusting medicine alongside. Timelines vary by program and by individual recovery.

What are the main risks of deep brain stimulation?

Surgical risks include bleeding in the brain, infection, seizures and anesthesia complications. Hardware risks include wire breakage, device malfunction, skin erosion and eventual battery replacement. Stimulation itself can cause speech changes, tingling, balance or mood effects, many of which settle with reprogramming. Teams can share their own complication rates, and asking for them is appropriate.

References

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Dr. Şule Eren
Dr. Şule Eren, MD
Author
View profile →
Published November 17, 2026
Keep Reading

More from the Blog

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.